NEW WHITE PAPER:  Solving Atypical Protein Expression with Transposase Technology    Dive in today!
Contact Us
Contact Us

AGC Biologics

2 min read

AGC Biologics Seattle site now certified to manufacture biologics for largest pharmaceutical market in South America

February 3, 2026 at 8:00 AM
Read press release
AGC Biologics and Fondazione Telethon celebrate regulatory approvals for gene therapy

3 min read

AGC Biologics Celebrates U.S. and EU Approval of Fondazione Telethon’s Waskyra™ Treatment for Wiskott-Aldrich Syndrome

January 16, 2026 at 11:00 AM
Read press release
AGC Bio and Asimov logo with viral vector image

2 min read

Asimov and AGC Biologics Team Up to Provide a Cost-Effective, Simplified, and Secure Manufacturing Approach for Viral Vector Production

January 12, 2026 at 4:00 AM
Read press release

3 min read

AGC Biologics Partners with ATUM to Accelerate Timelines for Cell Line Development

December 2, 2025 at 6:00 AM
Read press release
AGC Biologics partners with AAVantgarde

3 min read

AGC Biologics to Manufacture AAVantgarde’s Dual-Vector Gene Therapies for Inherited Retinal Disorders

November 21, 2025 at 12:00 AM
Read press release
AGC Biologics today announced it is partnering with Repair Biotechnologies to tackle one of the world's most persistent health challenges and cause of mortality.

2 min read

AGC Biologics and Repair Biotechnologies Partner on Novel mRNA Therapeutic to Combat the Leading Cause of Human Mortality

November 19, 2025 at 12:00 AM
Press Release mRNA Content
Read press release
Three workers in AGC Biologics Milan site review fill/finish procedures

3 min read

AGC Biologics Partners with Rarity PBC to Advance Life-Saving Gene Therapy for "Bubble Baby Disease"

October 23, 2025 at 12:00 AM
Cell & Gene Therapy Press Release
Read press release
Seattle site team member hard at work

2 min read

Seattle Facility Achieves Regulatory Approvals, Customer Satisfaction and Zero-Finding ISO Certification Inspection

September 10, 2025 at 8:00 AM
Mammalian & mAbs Press Release Business Updates Microbial
Read press release
Graphic with AGC Biologics and Autolus logos and notes EU market authorization for AUCATZYL

1 min read

European Commission Approves CAR-T Therapy With Lentiviral Vectors Manufactured by AGC Biologics

July 31, 2025 at 7:00 AM
Cell & Gene Therapy Press Release
Read press release

1 min read

AGC Biologics’ Heidelberg Site Supplies Drug Substance for Phase II Studies of Valneva’s Tetravalent Shigella Vaccine Candidate

July 29, 2025 at 7:00 AM
Press Release Microbial
Read press release
1 2 3 4 5 Next